Market Trends of Rapid Microbiology Testing Industry
Instruments Segment is Expected to Witness Significant Growth During the Forecast Period
- A wide range of instruments can be utilized for rapid microbiology testing. The rising demand for these instruments across different end-user segments is anticipated to drive the segment’s growth in the coming years. For instance, in February 2024, the Global Challenges Research Fund through Innovate UK, in collaboration with the Council for Scientific and Industrial Research-Ghana, trained farmers and other industry players in the aquaculture space on rapid bacteria testing kits to improve water quality. The training was aimed at achieving Ghana’s new Aquaculture Development Plan, which aims to increase the country’s fish farming output from ~89,500 metric tons in 2021 to ~212,000 metric tons by the end of 2027. Such vivid applications and new product launches are expected to drive the segment’s growth.
- Additionally, the rising applications of rapid microbiology testing instruments have led to the launch of advanced devices and kits from several players, targeting different industry verticals. For instance, in February 2024, Byonoy GmbH introduced Luminescence 96 Automate with accessible integration features on deck, allowing for seamless automated luminescence measurements. Similarly, in July 2023, PathogenDx launched Sero, a new rapid, single test that detects salmonella and 13 serotypes in a single shift to easily detect and control salmonella outbreaks in the poultry sector. Again, in June 2023, India’s Bengaluru-based startup GenWorks launched in vitro diagnostics (IVD) tests, including rapid card test kits for dengue and malaria. iScreen Dengue NS1 kit offers an immunochromatographic one-step rapid card solution for qualitative early acute dengue detection with NS1 antigen and differential detection of dengue IgG and IgM antibodies in human serum. Considering the rising cases of dengue globally, the demand for such rapid assay kits is expected to witness brisk growth. Such product launches globally aid in the adoption of rapid microbiology testing instruments and promote the growth of the segment.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Dominate the Rapid Microbiology Testing Market
- North America is expected to dominate the market due to higher acceptance of advanced technologies, well-developed research facilities, highly regulated industrial and healthcare landscape, developed healthcare infrastructure, established players in the region, and new product launches. For instance, in January 2024, Thermo Fisher Scientific launched the Invitrogen TaqMan Cells-to-CT Express Kit. The new kit is expected to offer simplified, scalable workflows for gene expression analysis through improved chemistry and facilitate the preparation of cell lysates for reverse transcription (RT) real-time PCR (qPCR) in just 5 minutes. Such advanced testing kits promote the adoption of rapid microbiology testing and are expected to drive market growth in the region.
- Additionally, the region has a widespread prevalence of acquired immunodeficiency syndrome (AIDS) caused by the human immunodeficiency virus (HIV). As per December 2023 data from HIV.gov, ~1.2 million people in the United States had HIV, while an estimated 13% of them were not aware of the same and required testing. The cumulative number has increased slightly owing to prolonged life expectancy because of effective treatment and ongoing new HIV infections. Early detection of AIDS can ensure higher life expectancy since the treatment can be started early. Owing to rising awareness of the same, there is a growing demand for rapid HIV testing kits. This, in turn, is expected to drive the demand in the rapid microbiology testing market.
- Furthermore, the market is driven by increased government initiatives and increasing adoption of rapid methods by the food and beverage industries. For instance, in December 2023, the FDA approved the SensiTox B. anthracis Toxin Test and SensiTox C. difficile Toxin Test of First Light Diagnostics. The development was supported in whole or in part with federal funds from the Administration for Strategic Preparedness and Response (ASPR), the Biomedical Advanced Research and Development Authority (BARDA), and the US Department of Health and Human Services (HHS). Similarly, in April 2023, the National Institute of Standards and Technology (NIST) hosted a workshop on collaborative efforts to enable the adoption of rapid microbial testing for advanced therapy products. The workshop aimed to promote rapid testing methodologies, considering emerging advanced therapy products require more rapid results. Such funding and initiatives promote the adoption of rapid microbiology testing products, thus contributing to market growth.
- Similar to the United States, Canada is also undertaking heavy research to ensure food safety. For instance, in March 2024, Hygiena, a leading food safety solutions provider, received official approval for the publication of its innovative method for detecting Escherichia coli O157:H7/NM in Raw Meat Products from Health Canada. Again, in April 2023, researchers at McMaster University in Ontario, Canada, developed the world's first rapid test for detecting salmonella bacteria in less than an hour. Presently available tests for salmonella are culture-based and can take up to a day to provide results. If approved, the rapid test kit can enable faster testing of food products and ensure the safety of consumers, according to the researchers. Such research and strategic initiatives by key players are expected to contribute to market growth.
- Therefore, owing to the presence of several prominent players, the launch of advanced products, and government initiatives and support, the market is expected to grow in North America.
Get Analysis on Important Geographic Markets
Download PDF
